BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35419815)

  • 21. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening.
    Stuart BD; Choi J; Zaidi S; Xing C; Holohan B; Chen R; Choi M; Dharwadkar P; Torres F; Girod CE; Weissler J; Fitzgerald J; Kershaw C; Klesney-Tait J; Mageto Y; Shay JW; Ji W; Bilguvar K; Mane S; Lifton RP; Garcia CK
    Nat Genet; 2015 May; 47(5):512-7. PubMed ID: 25848748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A concise review of telomere and telomerase-related genetic markers in fibrotic lung diseases].
    Fan YL; Ye Q
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Dec; 38(12):952-956. PubMed ID: 33406566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic pulmonary fibrosis: update on genetic discoveries.
    Garcia CK
    Proc Am Thorac Soc; 2011 May; 8(2):158-62. PubMed ID: 21543794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short telomeres are a risk factor for idiopathic pulmonary fibrosis.
    Alder JK; Chen JJ; Lancaster L; Danoff S; Su SC; Cogan JD; Vulto I; Xie M; Qi X; Tuder RM; Phillips JA; Lansdorp PM; Loyd JE; Armanios MY
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13051-6. PubMed ID: 18753630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis.
    Zhang D; Newton CA; Wang B; Povysil G; Noth I; Martinez FJ; Raghu G; Goldstein D; Garcia CK
    Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 36028256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Rare Missense Variant in Telomerase Reverse Transcriptase is Associated with Idiopathic Pulmonary Fibrosis in a Chinese Han Family.
    Zheng CM; Zhan X; Yang YH; Jiang T; Ye Q; Lu Y
    Chin Med J (Engl); 2018 Sep; 131(18):2205-2209. PubMed ID: 30203795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications.
    Hannan SJ; Iasella CJ; Sutton RM; Popescu ID; Koshy R; Burke R; Chen X; Zhang Y; Pilewski JM; Hage CA; Sanchez PG; Im A; Farah R; Alder JK; McDyer JF
    Am J Transplant; 2023 Oct; 23(10):1590-1602. PubMed ID: 37392813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-Phenotype Relationships in Inheritable Idiopathic Pulmonary Fibrosis: A Greek National Cohort Study.
    Manali ED; Kannengiesser C; Borie R; Ba I; Bouros D; Markopoulou A; Antoniou K; Kolilekas L; Papaioannou AI; Tzilas V; Tzouvelekis A; Daniil Z; Fouka E; Papakosta D; Xyfteri A; Karakatsani A; Loukides S; Korbila I; Tomos IP; Konstantinidis AK; Gogali A; Steiropoulos P; Papanikolaou IC; Bazaka C; Haritou A; Vassilakopoulos T; Maniati M; Kagouridis K; Markozannes E; Bouros E; Rampiadou C; Kounti G; Trachalaki A; Dimeas I; Karampitsakos T; Lyberopoulos P; Malamadakis N; Spyropoulou S; Revy P; Lainey E; Dieudé P; Rebah K; Ménard C; Oudin C; Masson C; Plessier A; Legendre M; Nathan N; Coulomb-L'Hermine A; Clement A; Amselem S; Boileau C; Crestani B; Papiris S;
    Respiration; 2022; 101(6):531-543. PubMed ID: 35078193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary Fibrosis and a TERT Founder Mutation With a Latency Period of 300 Years.
    van der Vis JJ; van der Smagt JJ; Hennekam FAM; Grutters JC; van Moorsel CHM
    Chest; 2020 Aug; 158(2):612-619. PubMed ID: 32315675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging.
    Piñeiro-Hermida S; Autilio C; Martínez P; Bosch F; Pérez-Gil J; Blasco MA
    J Cell Biol; 2020 Oct; 219(10):. PubMed ID: 32777016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations.
    Diaz de Leon A; Cronkhite JT; Yilmaz C; Brewington C; Wang R; Xing C; Hsia CCW; Garcia CK
    Chest; 2011 Sep; 140(3):753-763. PubMed ID: 21349926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomerase and telomere length in pulmonary fibrosis.
    Liu T; Ullenbruch M; Young Choi Y; Yu H; Ding L; Xaubet A; Pereda J; Feghali-Bostwick CA; Bitterman PB; Henke CA; Pardo A; Selman M; Phan SH
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):260-8. PubMed ID: 23526226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung transplant recipients with idiopathic pulmonary fibrosis have impaired alloreactive immune responses.
    Wang P; Leung J; Lam A; Lee S; Calabrese DR; Hays SR; Golden JA; Kukreja J; Singer JP; Wolters PJ; Tang Q; Greenland JR
    J Heart Lung Transplant; 2022 May; 41(5):641-653. PubMed ID: 34924263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of age and telomere length on circulating T cells and rejection risk after lung transplantation for idiopathic pulmonary fibrosis.
    Snyder ME; Anderson MR; Benvenuto LJ; Sutton RM; Bondonese A; Koshy R; Burke R; Clifford S; Craig A; Iasella CJ; Hannan SJ; Popescu I; Zhang Y; Sanchez PG; Alder JK; McDyer JF
    J Heart Lung Transplant; 2023 Dec; 42(12):1666-1677. PubMed ID: 37544465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic Fingerprint Associated with Familial Idiopathic Pulmonary Fibrosis: A Review.
    Ding D; Gao R; Xue Q; Luan R; Yang J
    Int J Med Sci; 2023; 20(3):329-345. PubMed ID: 36860670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary phenotypes associated with genetic variation in telomere-related genes.
    Hoffman TW; van Moorsel CHM; Borie R; Crestani B
    Curr Opin Pulm Med; 2018 May; 24(3):269-280. PubMed ID: 29474209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MMP19 Variants in Familial and Sporadic Idiopathic Pulmonary Fibrosis.
    Fan Y; Zheng C; Ma R; Wang J; Yang S; Ye Q
    Lung; 2023 Dec; 201(6):571-580. PubMed ID: 37971547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis.
    Petrovski S; Todd JL; Durheim MT; Wang Q; Chien JW; Kelly FL; Frankel C; Mebane CM; Ren Z; Bridgers J; Urban TJ; Malone CD; Finlen Copeland A; Brinkley C; Allen AS; O'Riordan T; McHutchison JG; Palmer SM; Goldstein DB
    Am J Respir Crit Care Med; 2017 Jul; 196(1):82-93. PubMed ID: 28099038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere Abnormalities in the Pathobiology of Idiopathic Pulmonary Fibrosis.
    Bilgili H; Białas AJ; Górski P; Piotrowski WJ
    J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31426295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
    Peljto AL; Zhang Y; Fingerlin TE; Ma SF; Garcia JG; Richards TJ; Silveira LJ; Lindell KO; Steele MP; Loyd JE; Gibson KF; Seibold MA; Brown KK; Talbert JL; Markin C; Kossen K; Seiwert SD; Murphy E; Noth I; Schwarz MI; Kaminski N; Schwartz DA
    JAMA; 2013 Jun; 309(21):2232-9. PubMed ID: 23695349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.